A "Snapshot" of an ovarian cancer clinical practice: Evidence for viewing the malignancy as a "chronic disease" Maurie Markman Editor’s Commentary Pages: 393 - 394
New agents in the treatment of childhood leukemias and myelodysplastic syndromes Seth J. Corey OriginalPaper Pages: 399 - 405
New paradigms for therapy for osteosarcoma Rajaram NagarajanDenis ClohisyBrenda Weigel OriginalPaper Pages: 410 - 414
Phase III clinical trial of maintenance therapy for patients with ovarian cancer Robert L. Coleman Clinical Trials Report Pages: 417 - 418
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer Krishnansu S. TewariBradley J. Monk OriginalPaper Pages: 419 - 434
Lymphatic mapping and sentinel node detection in gynecologic malignancies of the lower genital tract Michael FrumovitzPedro T. RamirezCharles Levenback OriginalPaper Pages: 435 - 443
The merits of vascular targeting for gynecologic malignancies Aparna A. KamatAnil K. Sood OriginalPaper Pages: 444 - 450
Secondary cytoreduction for patients with recurrent ovarian cancer Teresa P. Díaz-MontesRobert E. Bristow OriginalPaper Pages: 451 - 458
Quality of life and gynecologic malignancies Charlotte C. SunMichael FrumovitzDiane C. Bodurka OriginalPaper Pages: 459 - 465
How to establish a high-risk cancer genetics clinic: Limitations and successes Mary B. DalyBeth StearmanSusan Mazzoni OriginalPaper Pages: 469 - 474
What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer? Jonathan L. VelasquezSteven M. Lipkin OriginalPaper Pages: 475 - 479
